-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
OnKure Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2021 to Q2 2025.
- OnKure Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2025 was -1.14 USD/shares, a 97.5% increase year-over-year.
- OnKure Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2025 was 57 USD/shares.
- OnKure Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -15.3 USD/shares, a 87.7% increase from 2023.
- OnKure Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -124 USD/shares, a 5768% decline from 2022.
- OnKure Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.12 USD/shares, a 3.2% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)